Letteratura scientifica selezionata sul tema "Vaccinia virus"

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Vaccinia virus".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Articoli di riviste sul tema "Vaccinia virus"

1

Tartaglia, James, and Enzo Paoletti. "Recombinant vaccinia virus vaccines." Trends in Biotechnology 6, no. 2 (February 1988): 43–46. http://dx.doi.org/10.1016/0167-7799(88)90035-2.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Doria-Rose, N. A., C. Ohlen, P. Polacino, C. C. Pierce, M. T. Hensel, L. Kuller, T. Mulvania, et al. "Multigene DNA Priming-Boosting Vaccines Protect Macaques from Acute CD4+-T-Cell Depletion after Simian-Human Immunodeficiency Virus SHIV89.6P Mucosal Challenge." Journal of Virology 77, no. 21 (November 1, 2003): 11563–77. http://dx.doi.org/10.1128/jvi.77.21.11563-11577.2003.

Testo completo
Abstract (sommario):
ABSTRACT We evaluated four priming-boosting vaccine regimens for the highly pathogenic simian human immunodeficiency virus SHIV89.6P in Macaca nemestrina. Each regimen included gene gun delivery of a DNA vaccine expressing all SHIV89.6 genes plus Env gp160 of SHIV89.6P. Additional components were two recombinant vaccinia viruses, expressing SHIV89.6 Gag-Pol or Env gp160, and inactivated SHIV89.6 virus. We compared (i) DNA priming/DNA boosting, (ii) DNA priming/inactivated virus boosting, (iii) DNA priming/vaccinia virus boosting, and (iv) vaccinia virus priming/DNA boosting versus sham vaccine
Gli stili APA, Harvard, Vancouver, ISO e altri
3

KUTINOVA, L. "Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them." Vaccine 13, no. 5 (1995): 487–93. http://dx.doi.org/10.1016/0264-410x(94)00019-j.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Precopio, Melissa L., Michael R. Betts, Janie Parrino, David A. Price, Emma Gostick, David R. Ambrozak, Tedi E. Asher, et al. "Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses." Journal of Experimental Medicine 204, no. 6 (May 29, 2007): 1405–16. http://dx.doi.org/10.1084/jem.20062363.

Testo completo
Abstract (sommario):
Vaccinia virus immunization provides lifelong protection against smallpox, but the mechanisms of this exquisite protection are unknown. We used polychromatic flow cytometry to characterize the functional and phenotypic profile of CD8+ T cells induced by vaccinia virus immunization in a comparative vaccine trial of modified vaccinia virus Ankara (MVA) versus Dryvax immunization in which protection was assessed against subsequent Dryvax challenge. Vaccinia virus–specific CD8+ T cells induced by both MVA and Dryvax were highly polyfunctional; they degranulated and produced interferon γ, interleuk
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Truong, Cao-Sang, and So Young Yoo. "Oncolytic Vaccinia Virus in Lung Cancer Vaccines." Vaccines 10, no. 2 (February 4, 2022): 240. http://dx.doi.org/10.3390/vaccines10020240.

Testo completo
Abstract (sommario):
Therapeutic cancer vaccines represent a promising therapeutic modality via the induction of long-term immune response and reduction in adverse effects by specifically targeting tumor-associated antigens. Oncolytic virus, especially vaccinia virus (VV) is a promising cancer treatment option for effective cancer immunotherapy and thus can also be utilized in cancer vaccines. Non-small cell lung cancer (NSCLC) is likely to respond to immunotherapy, such as immune checkpoint inhibitors or cancer vaccines, since it has a high tumor mutational burden. In this review, we will summarize recent applica
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Jacobs, Bertram L., Jeffrey O. Langland, Karen V. Kibler, Karen L. Denzler, Stacy D. White, Susan A. Holechek, Shukmei Wong, Trung Huynh, and Carole R. Baskin. "Vaccinia virus vaccines: Past, present and future." Antiviral Research 84, no. 1 (October 2009): 1–13. http://dx.doi.org/10.1016/j.antiviral.2009.06.006.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Smith, Geoffrey L., Brendan J. Murphy, and Mansun Law. "Vaccinia Virus Motility." Annual Review of Microbiology 57, no. 1 (October 2003): 323–42. http://dx.doi.org/10.1146/annurev.micro.57.030502.091037.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Perkus, M. E. "RECOMBINANT VACCINIA VIRUS." Pediatric Infectious Disease Journal 5, no. 2 (March 1986): 284. http://dx.doi.org/10.1097/00006454-198603000-00045.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Broyles, Steven S. "Vaccinia virus transcription." Journal of General Virology 84, no. 9 (September 1, 2003): 2293–303. http://dx.doi.org/10.1099/vir.0.18942-0.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Stittelaar, Koert J., Geert van Amerongen, Ivanela Kondova, Thijs Kuiken, Rob F. van Lavieren, Frank H. M. Pistoor, Hubert G. M. Niesters, et al. "Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus." Journal of Virology 79, no. 12 (June 15, 2005): 7845–51. http://dx.doi.org/10.1128/jvi.79.12.7845-7851.2005.

Testo completo
Abstract (sommario):
ABSTRACT The use of classical smallpox vaccines based on vaccinia virus (VV) is associated with severe complications in both naïve and immune individuals. Modified vaccinia virus Ankara (MVA), a highly attenuated replication-deficient strain of VV, has been proven to be safe in humans and immunocompromised animals, and its efficacy against smallpox is currently being addressed. Here we directly compare the efficacies of MVA alone and in combination with classical VV-based vaccines in a cynomolgus macaque monkeypox model. The MVA-based smallpox vaccine protected macaques against a lethal respi
Gli stili APA, Harvard, Vancouver, ISO e altri
Più fonti

Tesi sul tema "Vaccinia virus"

1

Chan, Kenneth See Kit. "Nef from pathogenic simian immunodeficiency virus attenuates vaccinia virus /." For electronic version search Digital dissertations database. Restricted to UC campuses. Access is free to UC campus dissertations, 2004. http://uclibs.org/PID/11984.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Wallengren, Kristina. "Envelopment of retrovirus and vaccinia virus /." Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4851-8/.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Kettle, Susan. "Characterisation of vaccinia virus gene B13R." Thesis, University of Oxford, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294390.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Moore, Jeffrey B. "Vaccinia virus 3[beta]-hydroxysteroid dehydrogenase." Thesis, University of Oxford, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.359450.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Keller, Brian Andrew. "Functional Genomic Studies of Vaccinia Virus Provide Fundamental Insights into Virus-Host Interactions." Thesis, Université d'Ottawa / University of Ottawa, 2017. http://hdl.handle.net/10393/36614.

Testo completo
Abstract (sommario):
The oncolytic virus field is in the midst of strong and sustained growth. The clinical utility of this class of therapeutics has been bolstered in recent years by the rise of immune checkpoint inhibition, which has the potential to work synergistically with oncolytic viruses to increase the scope of patients who respond favourably to therapy. This growth has been further driven by clear industry support with several pharmaceutical companies acquiring or developing oncolytic virus products following the 2015 FDA approval of Talimogene laherparepvec and the generally-accepted potential of immuno
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Bleckwenn, Nicole Aleece. "Protein production development with recombinant vaccinia virus." College Park, Md. : University of Maryland, 2004. http://hdl.handle.net/1903/1416.

Testo completo
Abstract (sommario):
Thesis (Ph. D.) -- University of Maryland, College Park, 2004.<br>Thesis research directed by: Chemical Engineering. Title from t.p. of PDF. Includes bibliographical references. Published by UMI Dissertation Services, Ann Arbor, Mich. Also available in paper.
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Gardner, Jeremy Damien. "Characterisation of the vaccinia virus gene A39R." Thesis, University of Oxford, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.365448.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Major, James R. "Interactions of dendritic cells with vaccinia virus." Thesis, University of Oxford, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.401096.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Odell, Mark. "An analysis of vaccinia virus DNA ligase." Thesis, University of Oxford, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670258.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Napoli, Andrea. "Glycerophospholipid fluorescence imaging during vaccinia virus replication." Thesis, Sorbonne Paris Cité, 2019. https://theses.md.univ-paris-diderot.fr/NAPOLI_Andrea_1_va_20190415.pdf.

Testo completo
Abstract (sommario):
Le virus de la vaccine (VACV) est l'organisme modèle pour l'étude des Poxviridae. Son cycle de réplication dans le cytoplasme de la cellule hôte a été largement étudié par microscopie optique et microscopie électronique. Grâce à des études génétiques approfondies, le rôle de certaines des 250 protéines du virus a été élucidé. Cependant, les mécanismes d’acquisition de la membrane du virus, notamment le rôle des lipides cellulaires impliqués, restent mal connus. L’étude de la composition des membranes de VACV purifiés par spectrométrie de masse a montré qu’elles présentent un enrichissement en
Gli stili APA, Harvard, Vancouver, ISO e altri
Più fonti

Libri sul tema "Vaccinia virus"

1

Mercer, Jason, ed. Vaccinia Virus. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9593-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Isaacs, Stuart N., ed. Vaccinia Virus and Poxvirology. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1385/1592597890.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Isaacs, Stuart N., ed. Vaccinia Virus and Poxvirology. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-876-4.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Bennett, Alice Marie. Co-expression of vaccine antigens in vaccinia virus. Manchester: University of Manchester, 1995.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Neal, Isaacs Stuart, ed. Vaccinia virus and poxvirology: Methods and protocols. Totowa, N.J: Humana Press, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Carroll, Miles William. Expression analysis and immunogenicity of human immunodeficiency virus type 1 envelopeglycoprotein in vaccinia virus. Manchester: University of Manchester, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Xu, Fan. Construction of vaccinia virus recombinants carrying fragments of the rotavirus gene encoding VP7. [s.l.]: typescript, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Schneider, Henriette. Rescue of measles virus using the vaccinia vector MVA-T7 & analysis of recombinant measles viruses mutated in the RNA editing site. [s.l.]: [s.n.], 1996.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Ferran, Maureen C., and Gary R. Skuse, eds. Recombinant Virus Vaccines. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6869-5.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

1919-, Fukai Kōnosuke, and Japan Intractable Diseases Research Foundation., eds. Virus vaccines in Asian countries. [Tokyo]: University of Tokyo Press, 1986.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Più fonti

Capitoli di libri sul tema "Vaccinia virus"

1

Smith, G. L. "Recombinant vaccinia virus vaccines." In Recent Developments in Prophylactic Immunization, 313–33. Dordrecht: Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-1067-6_15.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Bartlett, D. L. "Vaccinia Virus." In Monographs in Virology, 130–59. Basel: KARGER, 2001. http://dx.doi.org/10.1159/000061723.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Shida, Hisatoshi. "Vaccinia Virus Hemagglutinin." In Subcellular Biochemistry, 405–40. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4899-1675-4_12.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Moss, Bernard. "Vaccinia virus vectors." In Biotechnology for Solving Agricultural Problems, 317–23. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-4396-4_24.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Moss, B. "Vaccinia Virus Vectors: Applications to Vaccines." In Progress in Immunology, 1131–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83755-5_151.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Smith, Geoffrey L., and Alain Vanderplasschen. "Extracellular Enveloped Vaccinia Virus." In Advances in Experimental Medicine and Biology, 395–414. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5331-1_51.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Chalikonda, Sricharan, and David L. Bartlett. "Vaccinia and Pox-Virus." In Gene Therapy for Cancer, 73–85. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-222-9_4.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Moss, Bernard. "Vaccinia Virus Expression Vectors." In Progress in Vaccinology, 415–21. New York, NY: Springer New York, 1989. http://dx.doi.org/10.1007/978-1-4612-3508-8_39.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Rooney, James F., Charles R. Wohlenberg, and Abner Louis Notkins. "Vaccinia Virus Recombinants as Potential Herpes Simplex Virus Vaccines." In Genetically Engineered Vaccines, 183–89. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3410-5_20.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Isaacs, Stuart N. "Working Safely with Vaccinia Virus." In Vaccinia Virus and Poxvirology, 1–13. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1385/1-59259-789-0:001.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri

Atti di convegni sul tema "Vaccinia virus"

1

Protsenko, M. A., E. I. Filippova, E. V. Makarevich, I. A. Gorbunova, T. V. Teplyakova, and N. A. Mazurkova. "ANTIVIRAL PROPERTIES OF EXTRACTS OF BASIDIOMYCETES OF THE NOVOSIBIRSK REGION." In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-259.

Testo completo
Abstract (sommario):
Dry ethanolic and aqueous extracts from fruiting bodies and cultivated mycelium of basidiomycetes were obtained and investigated for chemical composition. In vitro extracts are active against influenza virus A, herpes simplex virus type 2, vaccinia virus and mouse poxvirus. The in vivo antiviral activity of Fomes fomentarius mycelium extract against influenza virus subtype H3N2 was studied.
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Raafat, Nermin, Chantal Mengus, Michael Heberer, Giulio C. Spagnoli, and Paul Zajac. "Abstract 1500: Modulation of recombinant vaccinia virus vector immunogenicity." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1500.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Wang, Weiyi, Peihong Dai, Ning Yang, Stewart Shuman, Taha Merghoub, Jedd D. Wolchok, and Liang Deng. "Abstract A007: Intratumoral delivery of inactivated vaccinia virus is more efficacious than live oncolytic vaccinia virus in murine bilateral tumor implantation models." In Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-a007.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Ramachandran, Mohanraj, and Magnus Essand. "Abstract B181: Adenovirus, Semliki Forest virus and vaccinia virus-induced immunogenic cell death augments oncolytic virus immunotherapy." In Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-b181.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Trella, Emanuele. "Abstract A016: Multipotency of a CD40L-expressing recombinant vaccinia virus." In Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-a016.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Konyakhina, Yu V., A. A. Sergeev, K. A. Titova, S. A. Pyankov, S. N. Yakubitskiy, and S. N. Shchelkunov. "LOW-DOSE SMALLPOX VACCINATION IN A MOUSE MODEL." In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-254.

Testo completo
Abstract (sommario):
Vaccinia virus (VACV) strains caused a more pronounced production of antibodies with intradermal (i.d.) injection compared to scarification (s.s.) inoculation. To test for developed protective immunity at 62 day post vaccination (dpv), mice were intranasally infected with a cowpox virus. The results showed that i.d. injection provided the development of protective immunity in mice to a much greater extent compared to s.s. inoculation with VACV strains.
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Shulgina, I. S., S. N. Yakubitskiy, A. A. Sergeev, K. A. Titova, M. B. Borgoyakova, E. V. Starostina, L. I. Karpenko, and S. N. Shchelkunov. "EFFECT OF THE ATI GENE DELETION ON PATHOGENICITY AND IMMUNOGENICITY OF THE VACCINIA VIRUS." In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-268.

Testo completo
Abstract (sommario):
Among nonvirion proteins of the vaccinia virus (VACV), a 94-kDa protein (a truncated form of ATI protein) is synthesized in the largest quantity. This protein is a major immunogen upon infection of humans and animals with VACV. Meanwhile, antibodies specific to this protein are not virus-neutralizing. The present study aimed to investigate the effect of production of this protein on manifestation of pathogenicity and immunogenicity of VACV in a mouse model.
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Kim, Jee Hung, Woo Sun Kwon, Tae Soo Kim, Kyu Hyun Park, Joong Bae Ahn, Namhee Lee, Ji Won Choi, Hyun Cheol Chung, and Sun Young Rha. "Abstract B132: Antitumor effect of oncolytic vaccinia virus in gastric cancer." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1535-7163.targ-17-b132.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Panopoulos, Evangelos, Emanuele Trella, Nermin Raafat, Chantal Mengus, Giulio Spagnoli, and Paul Zajac. "Abstract 2843: Recombinant Vaccinia virus expressing CD40L: a multipotent antitumor immunogenic reagent." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2843.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

TIMIRYASOVA, TATYANA M., YONG A. YU, SHAHROKH SHABAHANG, ISTVAN FODOR, and ALADAR A. SZALAY. "VISUALIZATION OF VACCINIA VIRUS INFECTION USING THE RENILLA-LUCIFERASE-GFP FUSION PROTEIN." In Proceedings of the 11th International Symposium. WORLD SCIENTIFIC, 2001. http://dx.doi.org/10.1142/9789812811158_0111.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri

Rapporti di organizzazioni sul tema "Vaccinia virus"

1

Buckley, Patricia E., Kevin P. O'Connell, and Gary D. Ouellette. Review of Vaccinia Virus and Baculovirus Viability Versus Virucides. Fort Belvoir, VA: Defense Technical Information Center, March 2008. http://dx.doi.org/10.21236/ada480422.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Schurig, Gerhardt G. Expression of Brucella Antigens in Vaccinia Virus to Prevent Brucellosis in Humans: Protection Studies in Mice. Fort Belvoir, VA: Defense Technical Information Center, August 2000. http://dx.doi.org/10.21236/ada382850.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Gates, Sean Damien. Biophysical analysis of bacterial and viral systems. A shock tube study of bio-aerosols and a correlated AFM/nanosims investigation of vaccinia virus. Office of Scientific and Technical Information (OSTI), May 2013. http://dx.doi.org/10.2172/1108845.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Butler, Nadia, and Soha Karam. Evidence Review: COVID-19 Vaccine Acceptance by Key Influencers in the MENA Region - Teachers and Healthworkers. Institute of Development Studies (IDS), November 2021. http://dx.doi.org/10.19088/sshap.2021.039.

Testo completo
Abstract (sommario):
As COVID-19 vaccines have been deployed and scaled, concerns about vaccine acceptance have emerged. Effective management of the virus requires that communities everywhere buy into the public health measures designed to protect them, including vaccines. Low acceptance presents a serious challenge for achieving sufficient coverage to reduce circulation of the virus and the risk of new variants emerging. Surveys conducted early in the pandemic showed that the Middle East region had one of the lowest COVID-19 vaccine acceptance rates globally. The low acceptance is driven by specific factors in th
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Geisbert, Thomas W., and Peter B. Jahrling. Towards a Vaccine Against Ebola Virus. Fort Belvoir, VA: Defense Technical Information Center, January 2003. http://dx.doi.org/10.21236/ada428607.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Konakanchi, Lakshmi sravya. Vaccine Development for Respiratory Syncytial Virus. Ames (Iowa): Iowa State University, January 2020. http://dx.doi.org/10.31274/cc-20240624-1577.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Vakharia, Vikram, Shoshana Arad, Yonathan Zohar, Yacob Weinstein, Shamila Yusuff, and Arun Ammayappan. Development of Fish Edible Vaccines on the Yeast and Redmicroalgae Platforms. United States Department of Agriculture, February 2013. http://dx.doi.org/10.32747/2013.7699839.bard.

Testo completo
Abstract (sommario):
Betanodaviruses are causative agents of viral nervous necrosis (VNN), a devastating disease of cultured marine fish worldwide. Betanodavirus (BTN) genome is composed of two single-stranded, positive-sense RNA molecules. The larger genomic segment, RNA1 (3.1 kb), encodes the RNA-dependent RNA polymerase, while the smaller genomic segment, RNA 2 (1.4kb), encodes the coat protein. This structural protein is the host-protective antigen of VNN which assembles to form virus-like particles (VLPs). BTNs are classified into four genotypes, designated red-spotted grouper nervous necrosis virus (RGNNV),
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Heaton, Madeline. Review of Respiratory Syncytial Virus Vaccine Developments. Ames (Iowa): Iowa State University, May 2022. http://dx.doi.org/10.31274/cc-20240624-1234.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Lublin, A., H. Ly, E. Porter, S. Mor, Y. Farnoushi, and S. M. Goyal. Novel vaccination strategies to combat chicken arthritis/tenosynovitis reoviruses in US and Israel. Israel: United States-Israel Binational Agricultural Research and Development Fund, 2020. http://dx.doi.org/10.32747/2020.8134154.bard.

Testo completo
Abstract (sommario):
Objectives: The general objective of the research was to study the evolution of lameness/tendon rupture-associated CARVs (chicken avian reovirus) in the US and Israel with a view to develop novel vaccines for its control. -- Specific aims: 1. To perform comparative genomic analysis and phylodynamics of CARV strains from the US and Israel, to determine space-time distribution of variant viruses; to propose unified criteria for assigning them to genotypes and genotype constellations, to determine re-assortments and rate of substitutions in the re-emerging viruses, and to identify specific strain
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Trent, Dennis W. Development of a Genetically Engineered Venezuelan Equine Encephalitis Virus Vaccine. Fort Belvoir, VA: Defense Technical Information Center, April 1991. http://dx.doi.org/10.21236/ada237590.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!